跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,378 条关于
“IL-23 pathway”
全部
11,378
临床试验
3,259
药物
886
机构
156
资讯
7,077
7个月前
Icotrokinra Demonstrates Superior Efficacy Over Oral Therapies in Psoriasis Meta-Analysis
10个月前
FDA Approves Simplified Single-Injection Maintenance Regimen for Lilly's Omvoh in Ulcerative Colitis
11个月前
Johnson & Johnson's Icotrokinra Demonstrates Strong Efficacy in Phase 2b Ulcerative Colitis Trial
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
去年
Expanding Biologic Options Transform Treatment Landscape for Psoriatic Arthritis
去年
Protagonist to Present Phase 2b Icotrokinra Data for Ulcerative Colitis at European Gastroenterology Week
去年
Johnson & Johnson's Oral IL-23 Inhibitor Icotrokinra Shows Promise in Phase 3 Psoriasis Trials
去年
Mirikizumab Shows Long-Term Efficacy in Ulcerative Colitis and Crohn's Disease
去年
Oruka Therapeutics Initiates Phase 1 Trial of ORKA-001, a Novel IL-23p19 Antibody
10个月前
Protagonist Therapeutics Advances Multiple Drug Programs with Strong Financial Position Through 2028
第 1 页,共 708 页
上一页
下一页